Healthcare Professionals’ Knowledge and Behaviors Regarding Drug–Dietary Supplement and Drug–Herbal Product Interactions
No Thumbnail
Authors
Stanojević-Ristić, ZoricaMrkić, Isidora
Ćorac, Aleksandar
Dejanović, Mirjana
Mitić, Radoslav
Vitković, Leonida
Rašić, Julijana
Valjarević, Dragana

Valjarević, Aleksandar

Article (Published version)
Metadata
Show full item recordAbstract
Given the widespread use of dietary supplements (DS) and herbal products (HP), healthcare professionals (HCPs) will increasingly encounter patients who use these preparations with conventional drugs and who need their services to reduce the consequences of adverse therapeutic outcomes. The aim of our survey was to assess the knowledge and behaviors of HCPs regarding the risk of potential drug–dietary supplement (DDSIs) and drug–herbal product (DHPIs) interactions. This cross-sectional survey collected data via on paper-based questionnaire among general practitioners (GPs) (n = 105), specialty doctors (n = 87) and nurses (n = 154). The HCPs were mostly familiar with the interaction of doxycycline with magnesium (83%) and were least familiar with interaction of warfarin with glucosamine (14%). The results on DDSIs and DHPIs knowledge showed that GPs scored significantly higher than nurses (p < 0.001 and p = 0.003, respectively), while specialty doctors scored significantly higher than nu...rses only on DDSIs knowledge (p < 0.001). Only 28% of respondents reported that they often or always ask patients on drug therapy about the use of DS or HP, and 25% of respondents record such data in the medical documentation of patients. Our results showed that HCPs have sufficient knowledge about most major DDSIs and DHPIs, but insufficient knowledge about most moderate interactions. However, their overall knowledge and behavior regarding the risk of these interactions indicate the need for further continuing education and training
Keywords:
drug–dietary supplement interactions (DDSIs) / drug–herbal product interactions (DHPIs) / knowledge / behavior / healthcare professionals (HCPs)Source:
International Journal of Environmental Research and Public Health, 03-2022, 19, 7, 4290-Publisher:
- MDPI, Basel
DOI: 10.3390/ijerph19074290
ISSN: 1660-4601
WoS: 000781298200001
Scopus: 2-s2.0-85127411142
Collections
Institution/Community
Geografski fakultetTY - JOUR AU - Stanojević-Ristić, Zorica AU - Mrkić, Isidora AU - Ćorac, Aleksandar AU - Dejanović, Mirjana AU - Mitić, Radoslav AU - Vitković, Leonida AU - Rašić, Julijana AU - Valjarević, Dragana AU - Valjarević, Aleksandar PY - 2022-03 UR - http://gery.gef.bg.ac.rs/handle/123456789/1178 AB - Given the widespread use of dietary supplements (DS) and herbal products (HP), healthcare professionals (HCPs) will increasingly encounter patients who use these preparations with conventional drugs and who need their services to reduce the consequences of adverse therapeutic outcomes. The aim of our survey was to assess the knowledge and behaviors of HCPs regarding the risk of potential drug–dietary supplement (DDSIs) and drug–herbal product (DHPIs) interactions. This cross-sectional survey collected data via on paper-based questionnaire among general practitioners (GPs) (n = 105), specialty doctors (n = 87) and nurses (n = 154). The HCPs were mostly familiar with the interaction of doxycycline with magnesium (83%) and were least familiar with interaction of warfarin with glucosamine (14%). The results on DDSIs and DHPIs knowledge showed that GPs scored significantly higher than nurses (p < 0.001 and p = 0.003, respectively), while specialty doctors scored significantly higher than nurses only on DDSIs knowledge (p < 0.001). Only 28% of respondents reported that they often or always ask patients on drug therapy about the use of DS or HP, and 25% of respondents record such data in the medical documentation of patients. Our results showed that HCPs have sufficient knowledge about most major DDSIs and DHPIs, but insufficient knowledge about most moderate interactions. However, their overall knowledge and behavior regarding the risk of these interactions indicate the need for further continuing education and training PB - MDPI, Basel T2 - International Journal of Environmental Research and Public Health T1 - Healthcare Professionals’ Knowledge and Behaviors Regarding Drug–Dietary Supplement and Drug–Herbal Product Interactions VL - 19 IS - 7 SP - 4290 DO - 10.3390/ijerph19074290 ER -
@article{ author = "Stanojević-Ristić, Zorica and Mrkić, Isidora and Ćorac, Aleksandar and Dejanović, Mirjana and Mitić, Radoslav and Vitković, Leonida and Rašić, Julijana and Valjarević, Dragana and Valjarević, Aleksandar", year = "2022-03", abstract = "Given the widespread use of dietary supplements (DS) and herbal products (HP), healthcare professionals (HCPs) will increasingly encounter patients who use these preparations with conventional drugs and who need their services to reduce the consequences of adverse therapeutic outcomes. The aim of our survey was to assess the knowledge and behaviors of HCPs regarding the risk of potential drug–dietary supplement (DDSIs) and drug–herbal product (DHPIs) interactions. This cross-sectional survey collected data via on paper-based questionnaire among general practitioners (GPs) (n = 105), specialty doctors (n = 87) and nurses (n = 154). The HCPs were mostly familiar with the interaction of doxycycline with magnesium (83%) and were least familiar with interaction of warfarin with glucosamine (14%). The results on DDSIs and DHPIs knowledge showed that GPs scored significantly higher than nurses (p < 0.001 and p = 0.003, respectively), while specialty doctors scored significantly higher than nurses only on DDSIs knowledge (p < 0.001). Only 28% of respondents reported that they often or always ask patients on drug therapy about the use of DS or HP, and 25% of respondents record such data in the medical documentation of patients. Our results showed that HCPs have sufficient knowledge about most major DDSIs and DHPIs, but insufficient knowledge about most moderate interactions. However, their overall knowledge and behavior regarding the risk of these interactions indicate the need for further continuing education and training", publisher = "MDPI, Basel", journal = "International Journal of Environmental Research and Public Health", title = "Healthcare Professionals’ Knowledge and Behaviors Regarding Drug–Dietary Supplement and Drug–Herbal Product Interactions", volume = "19", number = "7", pages = "4290", doi = "10.3390/ijerph19074290" }
Stanojević-Ristić, Z., Mrkić, I., Ćorac, A., Dejanović, M., Mitić, R., Vitković, L., Rašić, J., Valjarević, D.,& Valjarević, A.. (2022-03). Healthcare Professionals’ Knowledge and Behaviors Regarding Drug–Dietary Supplement and Drug–Herbal Product Interactions. in International Journal of Environmental Research and Public Health MDPI, Basel., 19(7), 4290. https://doi.org/10.3390/ijerph19074290
Stanojević-Ristić Z, Mrkić I, Ćorac A, Dejanović M, Mitić R, Vitković L, Rašić J, Valjarević D, Valjarević A. Healthcare Professionals’ Knowledge and Behaviors Regarding Drug–Dietary Supplement and Drug–Herbal Product Interactions. in International Journal of Environmental Research and Public Health. 2022;19(7):4290. doi:10.3390/ijerph19074290 .
Stanojević-Ristić, Zorica, Mrkić, Isidora, Ćorac, Aleksandar, Dejanović, Mirjana, Mitić, Radoslav, Vitković, Leonida, Rašić, Julijana, Valjarević, Dragana, Valjarević, Aleksandar, "Healthcare Professionals’ Knowledge and Behaviors Regarding Drug–Dietary Supplement and Drug–Herbal Product Interactions" in International Journal of Environmental Research and Public Health, 19, no. 7 (2022-03):4290, https://doi.org/10.3390/ijerph19074290 . .